AGEN

Agenus (AGEN)

Agenus Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:AGEN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/09/23	18:45	PR Newswire (US)	AGEN LAWSUIT ALERT: The Gross Law Firm Notifies Agenus Inc. Investors of a Class Action Lawsuit and Upcoming Deadline	NASDAQ:AGEN	Agenus Inc
2024/09/19	18:45	PR Newswire (US)	Contact The Gross Law Firm by November 5, 2024 Deadline to Join Class Action Against Agenus Inc.(AGEN)	NASDAQ:AGEN	Agenus Inc
2024/09/16	18:45	PR Newswire (US)	The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Agenus Inc.(AGEN) Shareholders	NASDAQ:AGEN	Agenus Inc
2024/09/13	23:00	Business Wire	Botensilimab/Balstilimab Clinical Responses in Refractory Sarcomas Presented at ESMO 2024	NASDAQ:AGEN	Agenus Inc
2024/09/12	03:25	PR Newswire (US)	AGEN INVESTOR ALERT: Edelson Lechtzin LLP Urges Agenus, Inc. (NASDAQ: AGEN) Shareholders to Seek Legal Counsel About the Pending Securities Fraud Class Action	NASDAQ:AGEN	Agenus Inc
2024/09/09	20:30	Business Wire	Botensilimab/Balstilimab Clinical Activity in Refractory Sarcomas to be Presented in Oral Session at ESMO 2024	NASDAQ:AGEN	Agenus Inc
2024/09/03	20:30	Business Wire	Agenus to Participate in September Investor Conferences	NASDAQ:AGEN	Agenus Inc
2024/08/09	05:49	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGEN	Agenus Inc
2024/08/09	05:47	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:AGEN	Agenus Inc
2024/08/09	05:45	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:AGEN	Agenus Inc
2024/08/09	05:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGEN	Agenus Inc
2024/08/09	05:08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AGEN	Agenus Inc
2024/08/08	20:00	Business Wire	Agenus Reports Second Quarter 2024 Operational and Financial Results	NASDAQ:AGEN	Agenus Inc
2024/08/08	20:00	Business Wire	Agenus Announces Appointment of Tom Harrison to Board of Directors	NASDAQ:AGEN	Agenus Inc
2024/08/07	23:58	Business Wire	Agenus Publishes Seminal Study on Botensilimab’s Activity in Treatment-Resistant Cancers	NASDAQ:AGEN	Agenus Inc
2024/08/03	05:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGEN	Agenus Inc
2024/07/26	20:00	Business Wire	Agenus to Provide Second Quarter 2024 Financial Report and Corporate Update	NASDAQ:AGEN	Agenus Inc
2024/07/18	20:00	Business Wire	Agenus Announces End-of-Phase-2 Meeting Outcomes and Topline Interim Phase 2 Data for BOT/BAL in MSS Colorectal Cancer	NASDAQ:AGEN	Agenus Inc
2024/06/29	00:10	Business Wire	Significant Tumor Reductions in Neoadjuvant MSS Colon Cancer Patients Treated with Botensilimab/Balstilimab Presented at ESMO GI Conference	NASDAQ:AGEN	Agenus Inc
2024/06/27	20:30	Business Wire	Cancer Therapy Evaluation Program Announces Availability of Botensilimab for Clinical Studies	NASDAQ:AGEN	Agenus Inc
2024/06/19	05:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGEN	Agenus Inc
2024/06/19	05:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGEN	Agenus Inc
2024/06/19	05:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGEN	Agenus Inc
2024/06/19	05:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGEN	Agenus Inc
2024/06/18	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGEN	Agenus Inc
2024/06/17	20:00	Business Wire	Agenus Announces Appointment of Dr. Jennifer Buell to Its Board of Directors	NASDAQ:AGEN	Agenus Inc
2024/06/15	05:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGEN	Agenus Inc
2024/06/13	18:15	Business Wire	Nature Medicine Reports Agenus’ Novel Immunotherapy Demonstrates Clinical Activity Against a Deadly Form of Colorectal Cancer on the Rise in Americans Under 50	NASDAQ:AGEN	Agenus Inc
2024/06/04	20:30	Business Wire	Agenus Announces Virtual Annual Shareholders Meeting	NASDAQ:AGEN	Agenus Inc
2024/05/31	05:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AGEN	Agenus Inc